Additionally, the constant number of glucose-lowering medications throughout the study period and the predominant reduction in the total daily insulin dose suggested a minimal likelihood of overestimating the effect of escalating the dose of oral semaglutide, validating the obtained results
Semaglutide is a GLP-1 receptor agonist, a medication that mimics a hormone called glucagon-like peptide-1
Biomed Pharmacother 89:19 Allone C, Bonanno L, Buono VL, Corallo F, Palmeri R, Micchia K, Pollicino P, Bramanti A, Marino S (2020) Neuropsychological assessment and clinical evaluation in temporal lobe epilepsy with associated cortical dysplasia
Antioxidant imbalance in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice
- Biotin supplement (Vitamin B7) support: helps support energy metabolism and supports a consistent daily wellness routine